Donnelly JP - Search Results

1

Therapeutic drug monitoring of voriconazole.

Brüggemann RJ, Donnelly JP, Aarnoutse RE, Warris A, Blijlevens NM, Mouton JW, Verweij PE, Burger DM. Brüggemann RJ, et al. Among authors: donnelly jp. Ther Drug Monit. 2008 Aug;30(4):403-11. doi: 10.1097/FTD.0b013e31817b1a95. Ther Drug Monit. 2008. PMID: 18641555 Review.

2

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE; EUROFUNG Network. Meletiadis J, et al. Among authors: donnelly jp. Antimicrob Agents Chemother. 2002 Jan;46(1):62-8. doi: 10.1128/AAC.46.1.62-68.2002. Antimicrob Agents Chemother. 2002. PMID: 11751112 Free PMC article.

3

Impaired gut function as risk factor for invasive candidiasis in neutropenic patients.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Among authors: donnelly jp. Br J Haematol. 2002 May;117(2):259-64. doi: 10.1046/j.1365-2141.2002.03394.x. Br J Haematol. 2002. PMID: 11972507 Free article. Review. No abstract available.

4

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Mennink-Kersten MA, Donnelly JP, Verweij PE. Mennink-Kersten MA, et al. Among authors: donnelly jp. Lancet Infect Dis. 2004 Jun;4(6):349-57. doi: 10.1016/S1473-3099(04)01045-X. Lancet Infect Dis. 2004. PMID: 15172343 Review.

5

Validating PCR for detecting invasive aspergillosis.

Verweij PE, Klont RR, Donnelly JP. Verweij PE, et al. Among authors: donnelly jp. Br J Haematol. 2004 Oct;127(2):235-6. doi: 10.1111/j.1365-2141.2004.05181.x. Br J Haematol. 2004. PMID: 15461638 Free article. No abstract available.

6

Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE. Lutgens LC, et al. Among authors: donnelly jp. Cancer. 2005 Jan 1;103(1):191-9. doi: 10.1002/cncr.20733. Cancer. 2005. PMID: 15573372 Free article. Clinical Trial.

7

Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.

Klont RR, Mennink-Kersten MA, Ruegebrink D, Rijs AJ, Blijlevens NM, Donnelly JP, Verweij PE. Klont RR, et al. Among authors: donnelly jp. Clin Infect Dis. 2006 Aug 1;43(3):e23-5. doi: 10.1086/505603. Epub 2006 Jun 19. Clin Infect Dis. 2006. PMID: 16804836 Free article.

8

Microbiologic consequences of new approaches to managing hematologic malignancies.

Blijlevens NM, Donnelly JP, de Pauw BE. Blijlevens NM, et al. Among authors: donnelly jp. Rev Clin Exp Hematol. 2005 Dec;9(2):E2. Rev Clin Exp Hematol. 2005. PMID: 16864116 Review.

9

Halo sign and improved outcome.

Verweij PE, van Die L, Donnelly JP. Verweij PE, et al. Among authors: donnelly jp. Clin Infect Dis. 2007 Jun 15;44(12):1666-7; author reply 1667-8. doi: 10.1086/518387. Clin Infect Dis. 2007. PMID: 17516417 No abstract available.

10

Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.

Ament AJ, Hübben MW, Verweij PE, de Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL. Ament AJ, et al. Among authors: donnelly jp. J Antimicrob Chemother. 2007 Aug;60(2):385-93. doi: 10.1093/jac/dkm196. Epub 2007 Jun 7. J Antimicrob Chemother. 2007. PMID: 17561501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

458 results

Search Page